↓ Skip to main content

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy…

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing
Published in
Frontiers in oncology, July 2022
DOI 10.3389/fonc.2022.859846
Pubmed ID
Authors

Lisa A. Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, Shannon Terek, Margaret Harr, Hakon Hakonarson, Christine Cambareri, Jessica Marini, Jeffrey Landgraf, Jinbo Chen, Genevieve Kanter, Kelsey S. Lau-Min, Ryan C. Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 2 8%
Professor > Associate Professor 2 8%
Student > Doctoral Student 1 4%
Student > Bachelor 1 4%
Lecturer 1 4%
Other 4 17%
Unknown 13 54%
Readers by discipline Count As %
Medicine and Dentistry 5 21%
Biochemistry, Genetics and Molecular Biology 1 4%
Arts and Humanities 1 4%
Computer Science 1 4%
Chemistry 1 4%
Other 0 0%
Unknown 15 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2022.
All research outputs
#15,533,143
of 25,394,764 outputs
Outputs from Frontiers in oncology
#4,874
of 22,440 outputs
Outputs of similar age
#207,649
of 438,007 outputs
Outputs of similar age from Frontiers in oncology
#343
of 1,784 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,440 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 1,784 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.